NCT07001293 Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder
| NCT ID | NCT07001293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-04-26 |
| Primary Completion | 2028-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-04-26 with a primary completion date of 2028-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test a behavioral program for pregnant individuals with ADHD. This behavioral program focuses on skills for managing ADHD and related symptoms in pregnancy and postpartum. This pilot effectiveness-implementation trial aims to (1) preliminarily evaluate the MomMA behavioral intervention compared to treatment as usual (TAU) on clinical outcomes and (2) evaluate implementation outcomes, including feasibility and acceptability of clinic screening within existing OB workflows; assessment and intervention protocols; provider training/fidelity to manual; and all other study protocols from the perspective of real-world providers and participants.
Eligibility Criteria
Inclusion Criteria: 1. meets full DSM-5 criteria for ADHD 2. is between 14- and 22-weeks of gestation 3. 18 years of age or older 4. English speaking 5. Lives in Pennsylvania Exclusion Criteria: 1. substance use disorders requiring dual diagnosis treatment 2. intellectual disability 3. bipolar disorder, psychosis, and major depressive disorder with suicidal ideation 4. the following high complexity medical conditions during pregnancy: maternal cancer, multiples, placenta accreta, and/or fetus known to have a severe congenital condition
Contact & Investigator
Heather M Joseph, DO Assistant Professor of Psychiatry and Pediatrics
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT07001293 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07001293 currently recruiting?
Yes, NCT07001293 is actively recruiting participants. Contact the research team at wilsonm13@upmc.edu for enrollment information.
Where is the NCT07001293 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07001293 clinical trial?
NCT07001293 is sponsored by University of Pittsburgh. The principal investigator is Heather M Joseph, DO Assistant Professor of Psychiatry and Pediatrics at University of Pittsburgh. The trial plans to enroll 80 participants.